US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

118.48

+2.151.85%

Post-market: 118.480.00000.00%16:20 EDT

Volume:570.49K

Turnover:68.11M

Market Cap:9.85B

PE:-36.88

High:122.13

Open:119.12

Low:118.27

Close:116.33

52wk High:130.05

52wk Low:47.86

Shares:83.15M

Float Shares:64.87M

Volume Ratio:0.85

T/O Rate:0.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2122

EPS(LYR):-3.6900

ROE:-24.15%

ROA:-15.59%

PB:6.53

PE(LYR):-32.11

Loading ...

Overview Company News Filings

Kymera Therapeutics - Kt-621 Breadth Phase 2B Asthma Trial Data Expected in Late 2027

THOMSON REUTERS

Kymera Therapeutics Completes Enrollment in the Phase 2B Broaden2 Trial of Kt-621 in Atopic Dermatitis with Topline Data by Year-end 2026

THOMSON REUTERS

Kymera Therapeutics Shareholders Elect Booth, Mainolfi, Maraganore, Ridloff as Class III Directors

Kymera Therapeutics Names Felix Baker Board Chairman, Replacing Bruce Booth

Kymera Therapeutics Appoints Felix J. Baker, Ph.d., as Chairman of the Board of Directors

THOMSON REUTERS

Kymera Therapeutics Chief Business Officer Noah Goodman reports sale of 2,500 shares worth $247,500

Kymera Therapeutics (KYMR) Receives a Buy from Barclays

Kymera Therapeutics participates in a conference call with JPMorgan

Why Kymera Therapeutics (KYMR) Is Up 16.6% After Positive KT-621 Phase 1 Japanese Data

Simply Wall St.

Kymera reports Phase 1 data in healthy Japanese adults for KT-621 oral STAT6 degrader

Kymera Therapeutics posts corporate presentation outlining oral immunology protein degrader pipeline

Kymera Therapeutics, Sanofi dose first participant in Phase 1 trial of IRAK4 degrader KT-485

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral Irak4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

THOMSON REUTERS

Kymera Therapeutics - Eligible for up to $975 Mln in KT-485 Milestones

THOMSON REUTERS

Kymera Therapeutics - Receive S $20 Mln Milestone Payment From Sanofi

THOMSON REUTERS

Kymera Therapeutics: Buy Rating Reiterated as Analyst Maintains $110 Price Target on Emerging Protein Degrader Pipeline

Kymera Therapeutics COO Chadwick to Retire

Kymera Therapeutics COO Resigns, Transition Plan Implemented

Kymera Therapeutics names Penny Carlson SVP, Development Operations

Kymera Therapeutics Appoints Penny Carlson as Senior Vice President, Development Operations

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/KYMR/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":118.48,"timestamp":1789675200000,"preClose":116.33,"halted":0,"volume":570486,"hourTrading":{"tag":"盘后","latestPrice":118.48,"preClose":118.48,"latestTime":"16:20 EDT","volume":11111,"amount":1316431.28,"timestamp":1789676400306,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01848190492564262,"floatShares":64874597,"shares":83150618,"eps":-3.212195,"marketStatus":"Post-Mkt","change":2.15,"latestTime":"09-17 18:59:36 EDT","open":119.12,"high":122.13,"low":118.27,"amount":68111270,"amplitude":0.033181,"askPrice":118.5,"askSize":10,"bidPrice":116.17,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-3.212195,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"listingDate":1597982400000,"exchange":"NASDAQ","adjPreClose":116.33,"preHourTrading":{"tag":"盘前","latestPrice":117.15,"preClose":116.33,"latestTime":"09:14 EDT","volume":17,"amount":1987.509882,"timestamp":1789650851618,"change":0.82,"changeRate":0.007049,"amplitude":0.006533},"postHourTrading":{"tag":"盘后","latestPrice":118.48,"preClose":118.48,"latestTime":"16:20 EDT","volume":11111,"amount":1316431.28,"timestamp":1789676400306,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.84786,"impliedVol":0.6899,"impliedVolPercentile":0.5219},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","floatShares":64874597,"roa":"-15.59%","roe":"-24.15%","lyrEps":-3.69,"volumeRatio":0.84786,"shares":83150618,"dividePrice":0,"high":122.13,"amplitude":0.033181,"preClose":116.33,"low":118.27,"week52Low":47.86,"pbRate":"6.53","psRate":"93.83","week52High":130.05,"institutionHeld":0,"latestPrice":118.48,"committee":0.259259,"eps":-3.212195,"divideRate":0,"volume":570486,"delay":0,"ttmEps":-3.212195,"open":119.12,"prevYearClose":77.81,"prevWeekClose":114.96,"prevMonthClose":118.81,"prevQuarterClose":114.67,"fiveDayClose":117,"twentyDayClose":127.31,"sixtyDayClose":98.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYMR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"KYMR","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2026-04-30","symbol":"KYMR","fiscalQuarterEnding":"2026/03","expectedEps":-0.89,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"KYMR","fiscalQuarterEnding":"2025/12","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-0.97},{"market":"US","date":"2025-11-04","symbol":"KYMR","fiscalQuarterEnding":"2025/09","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-11","symbol":"KYMR","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3913,"buy":0.5217,"hold":0.087,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5217,"analysts":23,"updateTime":1789099200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYMR","date":"2026-09-16","current":-36.884436,"percent":0.085072,"low":-57.208045,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"high":-3.789687,"avg":-16.477769,"sd":9.906568,"marketCap":9408492426},"quantilePoints":[{"date":"2021-09-17","current":-54.930544,"twenty":-59.674378,"median":-46.53986,"eighty":-35.246583,"marketCap":3208328270},{"date":"2021-09-24","current":-54.537871,"twenty":-59.587037,"median":-46.809695,"eighty":-35.522327,"marketCap":3185393437},{"date":"2021-10-01","current":-52.54833,"twenty":-59.317994,"median":-46.890871,"eighty":-35.686253,"marketCap":3069190284},{"date":"2021-10-08","current":-48.51689,"twenty":-59.054061,"median":-47.083511,"eighty":-35.748479,"marketCap":2833726002},{"date":"2021-10-15","current":-49.91306,"twenty":-58.876157,"median":-47.068364,"eighty":-35.81053,"marketCap":2915272074},{"date":"2021-10-22","current":-48.586699,"twenty":-58.513954,"median":-47.083511,"eighty":-35.888209,"marketCap":2837803305},{"date":"2021-10-29","current":-51.379038,"twenty":-58.231387,"median":-47.634572,"eighty":-36.031291,"marketCap":3000895449},{"date":"2021-11-05","current":-56.66703,"twenty":-57.962548,"median":-47.834805,"eighty":-36.268304,"marketCap":3309751197},{"date":"2021-11-12","current":-40.862951,"twenty":-57.592374,"median":-47.792627,"eighty":-36.643399,"marketCap":3228254889},{"date":"2021-11-19","current":-39.959795,"twenty":-57.394247,"median":-47.611037,"eighty":-37.018397,"marketCap":3156903732},{"date":"2021-11-26","current":-34.950201,"twenty":-57.231083,"median":-47.083511,"eighty":-36.522189,"marketCap":2761135800},{"date":"2021-12-03","current":-34.534359,"twenty":-57.176853,"median":-46.939001,"eighty":-35.85679,"marketCap":2728283469},{"date":"2021-12-10","current":-34.469384,"twenty":-57.023938,"median":-46.854693,"eighty":-35.731094,"marketCap":2723150292},{"date":"2021-12-17","current":-35.067157,"twenty":-56.895652,"median":-46.777903,"eighty":-35.441994,"marketCap":2770375518},{"date":"2021-12-23","current":-40.135228,"twenty":-56.832825,"median":-46.53986,"eighty":-35.508989,"marketCap":3170763309},{"date":"2021-12-31","current":-41.252803,"twenty":-56.832825,"median":-46.231492,"eighty":-35.541476,"marketCap":3259053950},{"date":"2022-01-07","current":-36.100264,"twenty":-56.728112,"median":-46.187032,"eighty":-35.667949,"marketCap":2851993030},{"date":"2022-01-14","current":-26.685346,"twenty":-56.71066,"median":-46.004337,"eighty":-35.425245,"marketCap":2108195711},{"date":"2022-01-21","current":-24.716595,"twenty":-56.675756,"median":-45.799762,"eighty":-35.072355,"marketCap":1952660454},{"date":"2022-01-28","current":-25.002486,"twenty":-56.639106,"median":-45.704713,"eighty":-34.970993,"marketCap":1975246432},{"date":"2022-02-04","current":-25.814677,"twenty":-56.535547,"median":-45.445318,"eighty":-34.855337,"marketCap":2039411142},{"date":"2022-02-11","current":-27.315606,"twenty":-56.458749,"median":-45.224602,"eighty":-34.521364,"marketCap":2157987526},{"date":"2022-02-18","current":-25.210407,"twenty":-56.1271,"median":-44.939951,"eighty":-34.265806,"marketCap":1991672598},{"date":"2022-02-25","current":-20.657659,"twenty":-56.016065,"median":-44.903954,"eighty":-33.945704,"marketCap":2070248565},{"date":"2022-03-04","current":-18.502704,"twenty":-55.854061,"median":-44.772733,"eighty":-33.283828,"marketCap":1854285526},{"date":"2022-03-11","current":-19.812174,"twenty":-55.682188,"median":-44.495341,"eighty":-32.324854,"marketCap":1985516655},{"date":"2022-03-18","current":-22.317695,"twenty":-55.576416,"median":-44.339691,"eighty":-30.931725,"marketCap":2236612438},{"date":"2022-03-25","current":-20.843253,"twenty":-55.509604,"median":-44.227687,"eighty":-29.91279,"marketCap":2088848253},{"date":"2022-04-01","current":-21.477366,"twenty":-55.415713,"median":-43.894478,"eighty":-29.09307,"marketCap":2152397186},{"date":"2022-04-08","current":-18.368664,"twenty":-55.256898,"median":-43.540327,"eighty":-28.991566,"marketCap":1840852418},{"date":"2022-04-14","current":-19.611114,"twenty":-55.165513,"median":-43.260183,"eighty":-28.567245,"marketCap":1965366993},{"date":"2022-04-22","current":-17.46647,"twenty":-55.132037,"median":-42.908771,"eighty":-28.180145,"marketCap":1750437270},{"date":"2022-04-29","current":-16.167875,"twenty":-55.087613,"median":-42.53692,"eighty":-27.835849,"marketCap":1620295970},{"date":"2022-05-06","current":-7.934642,"twenty":-55.003842,"median":-42.089758,"eighty":-27.620703,"marketCap":982514932},{"date":"2022-05-13","current":-7.267865,"twenty":-54.946251,"median":-41.906186,"eighty":-27.280132,"marketCap":899950652},{"date":"2022-05-20","current":-6.163516,"twenty":-54.905754,"median":-41.694372,"eighty":-27.026289,"marketCap":763203563},{"date":"2022-05-27","current":-6.271867,"twenty":-54.823551,"median":-41.430782,"eighty":-26.775569,"marketCap":776620258},{"date":"2022-06-03","current":-6.442729,"twenty":-54.717338,"median":-41.342758,"eighty":-26.099247,"marketCap":797777355},{"date":"2022-06-10","current":-6.209357,"twenty":-54.557652,"median":-41.120121,"eighty":-25.818576,"marketCap":768879857},{"date":"2022-06-17","current":-6.571917,"twenty":-54.511693,"median":-40.89219,"eighty":-25.245293,"marketCap":813774184},{"date":"2022-06-24","current":-8.388883,"twenty":-54.40698,"median":-40.800208,"eighty":-25.002486,"marketCap":1038761847},{"date":"2022-07-01","current":-8.793116,"twenty":-54.382983,"median":-40.668026,"eighty":-24.716595,"marketCap":1088816442},{"date":"2022-07-08","current":-10.985145,"twenty":-54.363863,"median":-40.651043,"eighty":-23.157688,"marketCap":1360246513},{"date":"2022-07-15","current":-9.680763,"twenty":-54.250803,"median":-40.300689,"eighty":-21.912481,"marketCap":1198730140},{"date":"2022-07-22","current":-9.047325,"twenty":-53.993365,"median":-40.141071,"eighty":-21.396942,"marketCap":1120294074},{"date":"2022-07-29","current":-9.18068,"twenty":-53.858983,"median":-39.89482,"eighty":-20.83088,"marketCap":1136806930},{"date":"2022-08-05","current":-12.989642,"twenty":-53.679227,"median":-39.157098,"eighty":-20.482375,"marketCap":1608455379},{"date":"2022-08-12","current":-12.493565,"twenty":-53.411973,"median":-38.789003,"eighty":-19.900847,"marketCap":1741890302},{"date":"2022-08-19","current":-11.838735,"twenty":-53.337979,"median":-38.465388,"eighty":-19.728657,"marketCap":1650591936},{"date":"2022-08-26","current":-12.117757,"twenty":-53.305752,"median":-38.163943,"eighty":-19.253329,"marketCap":1689493966},{"date":"2022-09-02","current":-10.712799,"twenty":-53.124249,"median":-37.899038,"eighty":-18.792437,"marketCap":1493610607},{"date":"2022-09-09","current":-11.456778,"twenty":-53.075383,"median":-37.802616,"eighty":-18.455274,"marketCap":1597338383},{"date":"2022-09-16","current":-10.113974,"twenty":-53.00383,"median":-37.690264,"eighty":-18.059341,"marketCap":1410120528},{"date":"2022-09-23","current":-8.466696,"twenty":-52.853783,"median":-37.393272,"eighty":-17.438079,"marketCap":1180452113},{"date":"2022-09-30","current":-8.497924,"twenty":-52.783961,"median":-37.338809,"eighty":-16.517073,"marketCap":1184806017},{"date":"2022-10-07","current":-7.928012,"twenty":-52.663514,"median":-36.555091,"eighty":-13.054653,"marketCap":1105347276},{"date":"2022-10-14","current":-8.587704,"twenty":-52.572763,"median":-36.180368,"eighty":-12.555718,"marketCap":1197323490},{"date":"2022-10-21","current":-9.758755,"twenty":-52.555311,"median":-36.074274,"eighty":-11.951943,"marketCap":1360594875},{"date":"2022-10-28","current":-11.706602,"twenty":-52.454088,"median":-35.903918,"eighty":-11.606672,"marketCap":1632169612},{"date":"2022-11-04","current":-10.95052,"twenty":-52.280562,"median":-35.713709,"eighty":-11.366217,"marketCap":1684660854},{"date":"2022-11-11","current":-10.961165,"twenty":-52.141445,"median":-35.525233,"eighty":-11.186385,"marketCap":1686298568},{"date":"2022-11-18","current":-10.233733,"twenty":-52.033077,"median":-35.425245,"eighty":-11.029695,"marketCap":1574388174},{"date":"2022-11-25","current":-9.854049,"twenty":-51.965429,"median":-35.127475,"eighty":-10.972797,"marketCap":1515976407},{"date":"2022-12-02","current":-10.922132,"twenty":-51.872694,"median":-35.050913,"eighty":-10.933487,"marketCap":1680293620},{"date":"2022-12-09","current":-9.190488,"twenty":-51.760368,"median":-34.976191,"eighty":-10.762271,"marketCap":1413892292},{"date":"2022-12-16","current":-10.027923,"twenty":-51.690661,"median":-34.886786,"eighty":-10.631224,"marketCap":1542725721},{"date":"2022-12-23","current":-9.396298,"twenty":-51.643683,"median":-34.761773,"eighty":-10.461765,"marketCap":1445554745},{"date":"2022-12-30","current":-8.856934,"twenty":-51.58372,"median":-34.61629,"eighty":-10.350133,"marketCap":1362577282},{"date":"2023-01-06","current":-9.697917,"twenty":-51.379038,"median":-34.469384,"eighty":-10.297605,"marketCap":1491956615},{"date":"2023-01-13","current":-12.25635,"twenty":-51.256873,"median":-34.303957,"eighty":-10.297605,"marketCap":1885553659},{"date":"2023-01-20","current":-12.419579,"twenty":-51.251155,"median":-34.181877,"eighty":-10.303283,"marketCap":1910665260},{"date":"2023-01-27","current":-13.076042,"twenty":-51.153931,"median":-33.917788,"eighty":-10.324573,"marketCap":2011657566},{"date":"2023-02-03","current":-13.182496,"twenty":-51.098859,"median":-33.526965,"eighty":-10.344455,"marketCap":2028034697},{"date":"2023-02-10","current":-11.780858,"twenty":-51.090271,"median":-32.866801,"eighty":-10.35598,"marketCap":1812402475},{"date":"2023-02-17","current":-11.947635,"twenty":-51.021067,"median":-32.298777,"eighty":-10.366287,"marketCap":1838059980},{"date":"2023-02-24","current":-11.157115,"twenty":-50.808509,"median":-31.070369,"eighty":-10.408947,"marketCap":1727210659},{"date":"2023-03-03","current":-11.639431,"twenty":-50.542187,"median":-30.891255,"eighty":-10.455157,"marketCap":1801877108},{"date":"2023-03-10","current":-10.49393,"twenty":-50.361636,"median":-30.284071,"eighty":-10.48353,"marketCap":1624544291},{"date":"2023-03-17","current":-11.008164,"twenty":-50.140894,"median":-29.544301,"eighty":-10.497824,"marketCap":1704151903},{"date":"2023-03-24","current":-10.401722,"twenty":-50.020892,"median":-29.090731,"eighty":-10.455157,"marketCap":1610269823},{"date":"2023-03-31","current":-10.508116,"twenty":-49.98944,"median":-28.999526,"eighty":-10.388384,"marketCap":1626740363},{"date":"2023-04-06","current":-10.586137,"twenty":-49.949709,"median":-28.985983,"eighty":-10.415431,"marketCap":1638818759},{"date":"2023-04-14","current":-11.841579,"twenty":-49.849014,"median":-28.581203,"eighty":-10.448769,"marketCap":1833171135},{"date":"2023-04-21","current":-12.008262,"twenty":-49.732136,"median":-28.390444,"eighty":-10.474075,"marketCap":1858974981},{"date":"2023-04-28","current":-11.157632,"twenty":-49.657868,"median":-28.116374,"eighty":-10.487547,"marketCap":1727290638},{"date":"2023-05-05","current":-9.075289,"twenty":-49.553375,"median":-27.841432,"eighty":-10.487547,"marketCap":1443442877},{"date":"2023-05-12","current":-9.718931,"twenty":-49.490296,"median":-27.737946,"eighty":-10.381714,"marketCap":1545815421},{"date":"2023-05-19","current":-10.225916,"twenty":-49.450579,"median":-27.590189,"eighty":-10.319099,"marketCap":1626452351},{"date":"2023-05-26","current":-9.987943,"twenty":-49.384446,"median":-27.302611,"eighty":-10.268406,"marketCap":1588602363},{"date":"2023-06-02","current":-10.139694,"twenty":-49.354964,"median":-27.236588,"eighty":-10.236831,"marketCap":1612738587},{"date":"2023-06-08","current":-8.746348,"twenty":-49.319688,"median":-27.124925,"eighty":-10.222467,"marketCap":1391124169},{"date":"2023-06-16","current":-9.543038,"twenty":-49.101536,"median":-26.951745,"eighty":-10.153489,"marketCap":1517839344},{"date":"2023-06-23","current":-8.080715,"twenty":-48.944671,"median":-26.910903,"eighty":-10.113974,"marketCap":1285253915},{"date":"2023-06-30","current":-7.725481,"twenty":-48.714201,"median":-26.678849,"eighty":-10.083132,"marketCap":1228753209},{"date":"2023-07-07","current":-7.642708,"twenty":-48.581174,"median":-26.094071,"eighty":-10.029342,"marketCap":1215587996},{"date":"2023-07-14","current":-7.687543,"twenty":-48.550488,"median":-25.843916,"eighty":-9.996276,"marketCap":1222719153},{"date":"2023-07-21","current":-7.418531,"twenty":-48.452515,"median":-25.736707,"eighty":-9.976784,"marketCap":1179932211},{"date":"2023-07-28","current":-7.642708,"twenty":-48.322595,"median":-25.297621,"eighty":-9.91863,"marketCap":1215587996},{"date":"2023-08-04","current":-8.325772,"twenty":-48.26907,"median":-25.145432,"eighty":-9.856413,"marketCap":1312091662},{"date":"2023-08-11","current":-7.046225,"twenty":-48.239401,"median":-24.892029,"eighty":-9.804457,"marketCap":1110442734},{"date":"2023-08-18","current":-6.596466,"twenty":-48.152272,"median":-24.716595,"eighty":-9.765337,"marketCap":1039563411},{"date":"2023-08-25","current":-6.746385,"twenty":-48.032791,"median":-23.741966,"eighty":-9.707694,"marketCap":1063189852},{"date":"2023-09-01","current":-6.65225,"twenty":-47.951039,"median":-22.317695,"eighty":-9.667636,"marketCap":1048354644},{"date":"2023-09-08","current":-6.613898,"twenty":-47.924458,"median":-21.936196,"eighty":-9.572037,"marketCap":1042310671},{"date":"2023-09-15","current":-6.756845,"twenty":-47.90723,"median":-21.639761,"eighty":-9.529071,"marketCap":1064838208},{"date":"2023-09-22","current":-6.056058,"twenty":-47.860111,"median":-21.384569,"eighty":-9.413184,"marketCap":954398332},{"date":"2023-09-29","current":-4.985701,"twenty":-47.781558,"median":-20.887073,"eighty":-9.333925,"marketCap":785716531},{"date":"2023-10-06","current":-5.484271,"twenty":-47.716741,"median":-20.688591,"eighty":-9.24394,"marketCap":864288184},{"date":"2023-10-13","current":-4.351157,"twenty":-47.625158,"median":-20.459176,"eighty":-9.174333,"marketCap":685716245},{"date":"2023-10-20","current":-4.145453,"twenty":-47.489734,"median":-20.157585,"eighty":-9.106984,"marketCap":653298570},{"date":"2023-10-27","current":-4.012966,"twenty":-47.294195,"median":-19.910127,"eighty":-9.072011,"marketCap":632419390},{"date":"2023-11-03","current":-3.963586,"twenty":-47.080481,"median":-19.830218,"eighty":-8.938402,"marketCap":663738160},{"date":"2023-11-10","current":-4.696304,"twenty":-47.063128,"median":-19.683289,"eighty":-8.857001,"marketCap":786438288},{"date":"2023-11-17","current":-5.904393,"twenty":-46.987256,"median":-19.373965,"eighty":-8.803369,"marketCap":988743705},{"date":"2023-11-24","current":-6.540402,"twenty":-46.919749,"median":-19.080109,"eighty":-8.726901,"marketCap":1095249134},{"date":"2023-12-01","current":-6.805952,"twenty":-46.878192,"median":-18.817183,"eighty":-8.686608,"marketCap":1139717896},{"date":"2023-12-08","current":-7.763244,"twenty":-46.855589,"median":-18.510438,"eighty":-8.598634,"marketCap":1300025038},{"date":"2023-12-15","current":-8.34352,"twenty":-46.846723,"median":-18.368664,"eighty":-8.460015,"marketCap":1397197517},{"date":"2023-12-22","current":-8.294344,"twenty":-46.816053,"median":-18.030986,"eighty":-8.361665,"marketCap":1388962561},{"date":"2023-12-29","current":-8.79266,"twenty":-46.777903,"median":-17.79126,"eighty":-8.388883,"marketCap":1472410114},{"date":"2024-01-05","current":-8.923796,"twenty":-46.766793,"median":-17.452275,"eighty":-8.343329,"marketCap":1494369997},{"date":"2024-01-12","current":-9.674507,"twenty":-46.627671,"median":-17.043728,"eighty":-8.370738,"marketCap":1620083291},{"date":"2024-01-19","current":-9.548135,"twenty":-46.523894,"median":-16.749871,"eighty":-8.403522,"marketCap":1598921100},{"date":"2024-01-26","current":-11.176934,"twenty":-46.396169,"median":-14.953625,"eighty":-8.429475,"marketCap":1871678229},{"date":"2024-02-02","current":-11.471803,"twenty":-46.233294,"median":-13.281852,"eighty":-8.443505,"marketCap":1921056675},{"date":"2024-02-09","current":-11.928148,"twenty":-46.219098,"median":-13.205561,"eighty":-8.460015,"marketCap":1997475698},{"date":"2024-02-16","current":-13.135706,"twenty":-46.203228,"median":-13.097993,"eighty":-8.479187,"marketCap":2199692190},{"date":"2024-02-23","current":-16.837086,"twenty":-46.159109,"median":-13.182496,"eighty":-8.497945,"marketCap":2474411842},{"date":"2024-03-01","current":-17.756077,"twenty":-46.044123,"median":-13.272981,"eighty":-8.508435,"marketCap":2609468650},{"date":"2024-03-08","current":-17.756077,"twenty":-46.020308,"median":-13.374413,"eighty":-8.557588,"marketCap":2609468650},{"date":"2024-03-15","current":-16.42957,"twenty":-45.949772,"median":-13.662373,"eighty":-8.593169,"marketCap":2414522397},{"date":"2024-03-22","current":-16.974311,"twenty":-45.822699,"median":-16.167875,"eighty":-8.619808,"marketCap":2494578695},{"date":"2024-03-28","current":-16.704019,"twenty":-45.761534,"median":-16.421253,"eighty":-8.638924,"marketCap":2454856105},{"date":"2024-04-05","current":-15.069795,"twenty":-45.711642,"median":-16.371353,"eighty":-8.670473,"marketCap":2214687210},{"date":"2024-04-12","current":-15.473153,"twenty":-45.704713,"median":-16.157001,"eighty":-8.686608,"marketCap":2273965538},{"date":"2024-04-19","current":-14.604062,"twenty":-45.657644,"median":-15.55632,"eighty":-8.686608,"marketCap":2146242131},{"date":"2024-04-26","current":-13.923994,"twenty":-45.5064,"median":-15.136328,"eighty":-8.687717,"marketCap":2046298037},{"date":"2024-05-03","current":-14.407727,"twenty":-45.384235,"median":-14.959599,"eighty":-8.704809,"marketCap":2227304910},{"date":"2024-05-10","current":-15.324582,"twenty":-45.271672,"median":-15.123853,"eighty":-8.713937,"marketCap":2369042495},{"date":"2024-05-17","current":-14.129892,"twenty":-45.224602,"median":-15.056286,"eighty":-8.746348,"marketCap":2184354127},{"date":"2024-05-24","current":-13.590098,"twenty":-45.023652,"median":-14.844325,"eighty":-8.77228,"marketCap":2100906890},{"date":"2024-05-31","current":-12.744686,"twenty":-44.975332,"median":-14.700565,"eighty":-8.788584,"marketCap":1970213792},{"date":"2024-06-07","current":-13.082057,"twenty":-44.925971,"median":-14.537498,"eighty":-8.793025,"marketCap":2022368315},{"date":"2024-06-14","current":-13.213037,"twenty":-44.906953,"median":-14.383912,"eighty":-8.797997,"marketCap":2042616541},{"date":"2024-06-21","current":-12.697057,"twenty":-44.90384,"median":-14.292624,"eighty":-8.805809,"marketCap":1962850801},{"date":"2024-06-28","current":-11.847676,"twenty":-44.881476,"median":-14.217211,"eighty":-8.812693,"marketCap":1831544120},{"date":"2024-07-05","current":-12.006439,"twenty":-44.829216,"median":-14.127873,"eighty":-8.814742,"marketCap":1856087425},{"date":"2024-07-12","current":-16.789169,"twenty":-44.745164,"median":-14.169583,"eighty":-8.831969,"marketCap":2595454482},{"date":"2024-07-19","current":-17.106695,"twenty":-44.652302,"median":-14.288247,"eighty":-8.856979,"marketCap":2644541092},{"date":"2024-07-26","current":-17.678241,"twenty":-44.511281,"median":-14.383912,"eighty":-8.863292,"marketCap":2732896989},{"date":"2024-08-02","current":-16.685974,"twenty":-44.415386,"median":-14.439331,"eighty":-8.882836,"marketCap":2579501334},{"date":"2024-08-09","current":-16.211527,"twenty":-44.384878,"median":-14.691387,"eighty":-8.906376,"marketCap":2559054389},{"date":"2024-08-16","current":-17.13477,"twenty":-44.303137,"median":-14.819835,"eighty":-8.920794,"marketCap":2704792043},{"date":"2024-08-23","current":-19.297835,"twenty":-44.240444,"median":-15.042778,"eighty":-8.934868,"marketCap":3046240465},{"date":"2024-08-30","current":-19.532091,"twenty":-44.22788,"median":-15.130091,"eighty":-8.97565,"marketCap":3083218688},{"date":"2024-09-06","current":-18.336578,"twenty":-44.194716,"median":-15.213448,"eighty":-9.018995,"marketCap":2894502242},{"date":"2024-09-13","current":-18.611223,"twenty":-44.032244,"median":-15.280922,"eighty":-9.051279,"marketCap":2937856020},{"date":"2024-09-20","current":-20.109653,"twenty":-43.886709,"median":-15.45652,"eighty":-9.068733,"marketCap":3174389133},{"date":"2024-09-27","current":-19.665374,"twenty":-43.807738,"median":-15.639486,"eighty":-9.079877,"marketCap":3104258021},{"date":"2024-10-04","current":-17.391477,"twenty":-43.585821,"median":-15.656,"eighty":-9.106984,"marketCap":2745314241},{"date":"2024-10-11","current":-18.1831,"twenty":-43.426785,"median":-16.157001,"eighty":-9.143183,"marketCap":2870275131},{"date":"2024-10-18","current":-18.744507,"twenty":-43.269622,"median":-16.281044,"eighty":-9.152191,"marketCap":2958895353},{"date":"2024-10-25","current":-19.382652,"twenty":-43.188613,"median":-16.421253,"eighty":-9.17001,"marketCap":3059629132},{"date":"2024-11-01","current":-17.970803,"twenty":-42.953958,"median":-16.432042,"eighty":-9.174333,"marketCap":3009642282},{"date":"2024-11-08","current":-19.703301,"twenty":-42.897474,"median":-16.45452,"eighty":-9.181514,"marketCap":3299790710},{"date":"2024-11-15","current":-16.226703,"twenty":-42.824045,"median":-16.632072,"eighty":-9.185976,"marketCap":2717550897},{"date":"2024-11-22","current":-17.394593,"twenty":-42.641415,"median":-16.63794,"eighty":-9.198528,"marketCap":2913142024},{"date":"2024-11-29","current":-18.117756,"twenty":-42.362762,"median":-16.704019,"eighty":-9.230689,"marketCap":3034253086},{"date":"2024-12-06","current":-18.048147,"twenty":-42.117999,"median":-16.760212,"eighty":-9.274328,"marketCap":3022595337},{"date":"2024-12-13","current":-16.292445,"twenty":-42.089758,"median":-16.770553,"eighty":-9.296942,"marketCap":2728560993},{"date":"2024-12-20","current":-15.723969,"twenty":-42.026009,"median":-16.710256,"eighty":-9.297366,"marketCap":2633356040},{"date":"2024-12-27","current":-15.511274,"twenty":-41.948978,"median":-16.669034,"eighty":-9.299865,"marketCap":2597735140},{"date":"2025-01-03","current":-16.083617,"twenty":-41.901479,"median":-16.632072,"eighty":-9.317721,"marketCap":2693587745},{"date":"2025-01-10","current":-14.761041,"twenty":-41.841229,"median":-16.510768,"eighty":-9.338641,"marketCap":2472090508},{"date":"2025-01-17","current":-15.704633,"twenty":-41.745207,"median":-16.439891,"eighty":-9.354352,"marketCap":2630117777},{"date":"2025-01-24","current":-17.154827,"twenty":-41.651541,"median":-16.567015,"eighty":-9.358228,"marketCap":2872987554},{"date":"2025-01-31","current":-15.310181,"twenty":-41.477861,"median":-16.437202,"eighty":-9.370749,"marketCap":2564057197},{"date":"2025-02-07","current":-14.43233,"twenty":-41.453375,"median":-16.425411,"eighty":-9.413184,"marketCap":2417040025},{"date":"2025-02-14","current":-14.262174,"twenty":-41.388207,"median":-16.396436,"eighty":-9.48073,"marketCap":2388543305},{"date":"2025-02-21","current":-14.235104,"twenty":-41.36853,"median":-16.354374,"eighty":-9.48073,"marketCap":2384009735},{"date":"2025-02-28","current":-9.095045,"twenty":-41.316985,"median":-16.292445,"eighty":-9.48073,"marketCap":2035998663},{"date":"2025-03-07","current":-9.54182,"twenty":-41.252803,"median":-16.219115,"eighty":-9.364362,"marketCap":2136012633},{"date":"2025-03-14","current":-9.971187,"twenty":-41.120121,"median":-16.157001,"eighty":-9.396298,"marketCap":2232129954},{"date":"2025-03-21","current":-9.44028,"twenty":-41.064375,"median":-15.882524,"eighty":-9.44028,"marketCap":2113282185},{"date":"2025-03-28","current":-8.59315,"twenty":-40.921429,"median":-15.785844,"eighty":-9.356694,"marketCap":1923645308},{"date":"2025-04-04","current":-6.402796,"twenty":-40.862951,"median":-15.746717,"eighty":-9.297366,"marketCap":1433317081},{"date":"2025-04-11","current":-6.997528,"twenty":-40.836961,"median":-15.704633,"eighty":-9.230689,"marketCap":1566452560},{"date":"2025-04-17","current":-7.534237,"twenty":-40.778157,"median":-15.657984,"eighty":-9.184014,"marketCap":1686599211},{"date":"2025-04-25","current":-9.649161,"twenty":-40.687293,"median":-15.64736,"eighty":-9.172062,"marketCap":2160041963},{"date":"2025-05-02","current":-10.262501,"twenty":-40.668071,"median":-15.580884,"eighty":-9.179093,"marketCap":2297342930},{"date":"2025-05-09","current":-8.129065,"twenty":-40.65763,"median":-15.513208,"eighty":-9.146726,"marketCap":1958145409},{"date":"2025-05-16","current":-8.177726,"twenty":-40.651841,"median":-15.473153,"eighty":-9.07365,"marketCap":1969866932},{"date":"2025-05-23","current":-8.156099,"twenty":-40.649035,"median":-15.377323,"eighty":-8.951301,"marketCap":1964657366},{"date":"2025-05-30","current":-8.177726,"twenty":-40.441912,"median":-15.295552,"eighty":-8.913864,"marketCap":1969866932},{"date":"2025-06-06","current":-12.884311,"twenty":-40.299994,"median":-15.236704,"eighty":-8.913864,"marketCap":3103598610},{"date":"2025-06-13","current":-12.784286,"twenty":-40.274094,"median":-15.203654,"eighty":-8.921794,"marketCap":3079504370},{"date":"2025-06-20","current":-12.554499,"twenty":-40.211637,"median":-15.136243,"eighty":-8.934518,"marketCap":3024152737},{"date":"2025-06-27","current":-12.357152,"twenty":-40.138734,"median":-15.10522,"eighty":-8.95095,"marketCap":2976615453},{"date":"2025-07-03","current":-13.046424,"twenty":-40.100141,"median":-15.069795,"eighty":-8.963563,"marketCap":3142648605},{"date":"2025-07-11","current":-13.168761,"twenty":-39.933805,"median":-14.938931,"eighty":-9.018995,"marketCap":3172117514},{"date":"2025-07-18","current":-13.50082,"twenty":-39.812951,"median":-14.849403,"eighty":-9.051279,"marketCap":3252104551},{"date":"2025-07-25","current":-13.35518,"twenty":-39.627721,"median":-14.778193,"eighty":-9.068733,"marketCap":3217022517},{"date":"2025-08-01","current":-12.743493,"twenty":-39.147269,"median":-14.691387,"eighty":-9.07924,"marketCap":3069677975},{"date":"2025-08-08","current":-11.898781,"twenty":-39.064709,"median":-14.515474,"eighty":-9.095682,"marketCap":2866202177},{"date":"2025-08-15","current":-10.785615,"twenty":-38.850637,"median":-14.43233,"eighty":-9.106984,"marketCap":2970725155},{"date":"2025-08-22","current":-11.05558,"twenty":-38.768458,"median":-14.383912,"eighty":-9.124493,"marketCap":3045082656},{"date":"2025-08-29","current":-10.837532,"twenty":-38.768458,"median":-14.26484,"eighty":-9.124493,"marketCap":2985024674},{"date":"2025-09-05","current":-10.954343,"twenty":-38.809548,"median":-14.147693,"eighty":-9.115738,"marketCap":3017198593},{"date":"2025-09-12","current":-11.99267,"twenty":-38.768458,"median":-14.036722,"eighty":-9.124493,"marketCap":3303188981},{"date":"2025-09-19","current":-13.280194,"twenty":-38.768458,"median":-13.923994,"eighty":-9.124493,"marketCap":3657817062},{"date":"2025-09-26","current":-13.948617,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":3841923374},{"date":"2025-10-03","current":-14.536569,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4003865432},{"date":"2025-10-10","current":-14.801343,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4076792980},{"date":"2025-10-17","current":-15.694303,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4322744714},{"date":"2025-10-24","current":-14.993433,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4129701202},{"date":"2025-10-31","current":-15.948693,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4392812359},{"date":"2025-11-07","current":-14.871445,"twenty":-38.510575,"median":-13.732985,"eighty":-9.124493,"marketCap":4388890647},{"date":"2025-11-14","current":-15.512624,"twenty":-37.938352,"median":-13.732985,"eighty":-9.124493,"marketCap":4578116588},{"date":"2025-11-21","current":-15.756418,"twenty":-37.652889,"median":-13.732985,"eighty":-9.124493,"marketCap":4650065615},{"date":"2025-11-28","current":-16.548749,"twenty":-37.32898,"median":-13.732985,"eighty":-9.124493,"marketCap":4883899952},{"date":"2025-12-05","current":-16.146489,"twenty":-36.08467,"median":-13.732985,"eighty":-9.124493,"marketCap":4765184058},{"date":"2025-12-12","current":-23.802748,"twenty":-35.592065,"median":-13.732985,"eighty":-9.124493,"marketCap":7024714560},{"date":"2025-12-19","current":-21.585387,"twenty":-35.069756,"median":-13.732985,"eighty":-9.124493,"marketCap":6370322520},{"date":"2025-12-26","current":-22.534135,"twenty":-34.960597,"median":-13.732985,"eighty":-9.124493,"marketCap":6650319114},{"date":"2026-01-02","current":-21.092037,"twenty":-34.674483,"median":-13.732985,"eighty":-9.124493,"marketCap":6224724290},{"date":"2026-01-09","current":-20.324906,"twenty":-33.447973,"median":-13.732985,"eighty":-9.124493,"marketCap":5998327044},{"date":"2026-01-16","current":-19.278572,"twenty":-29.680357,"median":-13.732985,"eighty":-9.124493,"marketCap":5689530800},{"date":"2026-01-23","current":-19.725839,"twenty":-27.736646,"median":-13.732985,"eighty":-9.124493,"marketCap":5821529194},{"date":"2026-01-30","current":-20.03486,"twenty":-26.936151,"median":-13.732985,"eighty":-9.124493,"marketCap":5912728085},{"date":"2026-02-06","current":-20.585135,"twenty":-25.879653,"median":-13.732985,"eighty":-9.124493,"marketCap":6075126110},{"date":"2026-02-13","current":-22.775389,"twenty":-25.350754,"median":-13.732985,"eighty":-9.124493,"marketCap":6721518248},{"date":"2026-02-20","current":-23.447645,"twenty":-24.971298,"median":-13.732985,"eighty":-9.124493,"marketCap":6919915835},{"date":"2026-02-27","current":-24.821424,"twenty":-24.616503,"median":-13.732985,"eighty":-9.124493,"marketCap":7728175245},{"date":"2026-03-06","current":-21.900597,"twenty":-23.960592,"median":-13.732985,"eighty":-9.124493,"marketCap":6818772746},{"date":"2026-03-13","current":-20.322034,"twenty":-23.398123,"median":-13.732985,"eighty":-9.124493,"marketCap":6327285535},{"date":"2026-03-20","current":-20.864829,"twenty":-22.914822,"median":-13.732985,"eighty":-9.124493,"marketCap":6496285290},{"date":"2026-03-27","current":-21.024783,"twenty":-22.604919,"median":-13.732985,"eighty":-9.124493,"marketCap":6546087150},{"date":"2026-04-02","current":-22.270327,"twenty":-22.323196,"median":-13.732985,"eighty":-9.124493,"marketCap":6933888522},{"date":"2026-04-10","current":-22.904899,"twenty":-22.318613,"median":-13.732985,"eighty":-9.124493,"marketCap":7131463115},{"date":"2026-04-17","current":-22.587613,"twenty":-22.31602,"median":-13.732985,"eighty":-9.124493,"marketCap":7032675819},{"date":"2026-04-24","current":-22.857699,"twenty":-22.31602,"median":-13.732985,"eighty":-9.124493,"marketCap":7116767484},{"date":"2026-05-01","current":-21.011634,"twenty":-22.281865,"median":-13.732985,"eighty":-9.124493,"marketCap":6618748881},{"date":"2026-05-08","current":-22.099591,"twenty":-22.131175,"median":-13.732985,"eighty":-9.124493,"marketCap":6961459672},{"date":"2026-05-15","current":-22.065644,"twenty":-22.052131,"median":-13.732985,"eighty":-9.124493,"marketCap":6950766186},{"date":"2026-05-22","current":-21.049841,"twenty":-21.895877,"median":-13.732985,"eighty":-9.124493,"marketCap":6630784168},{"date":"2026-05-29","current":-21.271803,"twenty":-21.811404,"median":-13.727031,"eighty":-9.115738,"marketCap":6700703118},{"date":"2026-06-05","current":-19.48305,"twenty":-21.578881,"median":-13.732985,"eighty":-9.124493,"marketCap":6137238640},{"date":"2026-06-12","current":-21.663501,"twenty":-21.439081,"median":-13.732985,"eighty":-9.124493,"marketCap":6824089500},{"date":"2026-06-18","current":-23.475756,"twenty":-21.439081,"median":-13.732985,"eighty":-9.124493,"marketCap":7394957161},{"date":"2026-06-26","current":-30.411419,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9579718698},{"date":"2026-07-02","current":-29.821261,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9393816549},{"date":"2026-07-10","current":-31.074694,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9788652972},{"date":"2026-07-17","current":-29.766423,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9376542456},{"date":"2026-07-24","current":-28.823737,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9079592563},{"date":"2026-07-31","current":-27.943723,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":8802384491},{"date":"2026-08-07","current":-29.532803,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":8848057261},{"date":"2026-08-14","current":-31.755881,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9514093711},{"date":"2026-08-21","current":-33.720849,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":10102800087},{"date":"2026-08-28","current":-33.368376,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9997198802},{"date":"2026-09-04","current":-32.549639,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9751904479},{"date":"2026-09-11","current":-32.471929,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9728622306},{"date":"2026-09-16","current":-31.403408,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9408492426}],"updateTime":1789685976989},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYMR\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2646874714","title":"Kymera Therapeutics - Kt-621 Breadth Phase 2B Asthma Trial Data Expected in Late 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874714?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:00","pubTimestamp":1782385200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA7KJ2HY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646874050","title":"Kymera Therapeutics Completes Enrollment in the Phase 2B Broaden2 Trial of Kt-621 in Atopic Dermatitis with Topline Data by Year-end 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874050?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:00","pubTimestamp":1782385200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA7KJ2HY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646845541","title":"Kymera Therapeutics Shareholders Elect Booth, Mainolfi, Maraganore, Ridloff as Class III Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2646845541","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646845541?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:11","pubTimestamp":1782331883,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics shareholders elect Booth, Mainolfi, Maraganore, Ridloff as Class III directorsKymera Therapeutics held its annual shareholder meeting on June 24, 2026.Shareholders backed the slate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL3hBJyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646430348","title":"Kymera Therapeutics Names Felix Baker Board Chairman, Replacing Bruce Booth","url":"https://stock-news.laohu8.com/highlight/detail?id=2646430348","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646430348?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:01","pubTimestamp":1782331299,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics names Felix Baker board chairman, replacing Bruce BoothKymera Therapeutics named Felix J. Baker as board chairman, succeeding co-founder Bruce Booth, who will remain an independent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL25wLpc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4139","SG9999014039.USD","SG9999014005.SGD","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","NDAQ","SG9999014013.SGD","BK4112","SG9999014021.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646437018","title":"Kymera Therapeutics Appoints Felix J. Baker, Ph.d., as Chairman of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2646437018","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646437018?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:01","pubTimestamp":1782331260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA8N11LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645741008","title":"Kymera Therapeutics Chief Business Officer Noah Goodman reports sale of 2,500 shares worth $247,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2645741008","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645741008?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:48","pubTimestamp":1782164885,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Chief Business Officer Noah Goodman sold 2,500 common shares at USD 99 on June 22, 2026.The sale followed the exercise of stock options for 2,500 shares at USD 21.05.Goodman’s direct holdings stood at 50,195 common shares after the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL2CxblV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kymera Therapeutics Chief Business Officer Noah Goodman reports sale of 2,500 shares worth $247,500","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645873028","title":"Kymera Therapeutics (KYMR) Receives a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2645873028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645873028?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:42","pubTimestamp":1782117722,"startTime":"0","endTime":"0","summary":"In a report released today, Eliana Merle from Barclays maintained a Buy rating on Kymera Therapeutics, with a price target of $133.00. According to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kymera-therapeutics-kymr-receives-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kymera-therapeutics-kymr-receives-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644723594","title":"Kymera Therapeutics participates in a conference call with JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644723594","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644723594?lang=en_us&edition=fundamental","pubTime":"2026-06-18 01:25","pubTimestamp":1781717112,"startTime":"0","endTime":"0","summary":"JPMorgan holds a conference call with management on June 17 at 2 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, ma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kymera-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kymera-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0170899867.USD","KYMR","JPO","LU1162221912.USD","IE00B775SV38.USD","IE000M9KFDE8.USD","IE00BFXG1179.USD","LU0345770993.USD","LU0211328371.USD","LU1116320737.USD","LU2430703095.HKD","LU0345769128.USD","LU1116320901.HKD","LU2054465674.USD","LU2023250330.USD","LU1988902786.USD","LU0640476718.USD","LU0868494708.USD","JPMO","IE00B3S45H60.SGD","IE00BWXC8680.SGD","LU0345769631.USD","LU0942090050.USD","LU2357305700.SGD","LU1917777945.USD","IE00BJTD4N35.SGD","LU1670627923.USD","LU0234572021.USD","SG9999002232.USD","JPM","LU1720051108.HKD","BK4534","PGF","LU2237443895.HKD","LU2211815571.USD","LU1496350502.SGD","LU0215105999.USD","LU1668664300.SGD","JPX","LU0211331839.USD","LU1280957306.USD","LU0106261372.USD","LU0203345920.USD","LU0868494617.USD","LU1363072403.SGD","LU2213496289.HKD","LU0238689110.USD","IE00B1XK9C88.USD","LU1551013425.SGD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643881307","title":"Why Kymera Therapeutics (KYMR) Is Up 16.6% After Positive KT-621 Phase 1 Japanese Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2643881307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643881307?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:15","pubTimestamp":1781547329,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics recently reported Phase 1 data from KT-621, its first-in-class oral STAT6 degrader, in healthy Japanese adults at the Japanese Dermatological Association meeting in Kyoto, showing rapid, sustained STAT6 degradation, robust biomarker effects and a favorable safety profile consistent with earlier studies.\nBy aligning pharmacokinetic, pharmacodynamic and safety data in Japanese participants with prior global results, Kymera cleared an important regulatory step toward...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kymr/kymera-therapeutics/news/why-kymera-therapeutics-kymr-is-up-166-after-positive-kt-621","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kymr/kymera-therapeutics/news/why-kymera-therapeutics-kymr-is-up-166-after-positive-kt-621","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0541502299.USD","SG9999004220.SGD","KT","BK4139","BK4115","LU0541501648.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642267599","title":"Kymera reports Phase 1 data in healthy Japanese adults for KT-621 oral STAT6 degrader","url":"https://stock-news.laohu8.com/highlight/detail?id=2642267599","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642267599?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:01","pubTimestamp":1781262061,"startTime":"0","endTime":"0","summary":"Kymera presented Phase 1 results for KT-621, an oral STAT6 degrader, in healthy Japanese adults at the Japanese Dermatological Association meeting.The study supported consistent drug behavior and a favorable tolerability profile versus earlier KT-621 Phase 1 work in non-Japanese volunteers.Results cleared the regulatory step needed to enroll patients in Japan into ongoing global Phase 2b trials in atopic dermatitis and asthma.Phase 2b readouts are expected by mid-2027 for atopic dermatitis, late 2027 for asthma.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9GkKkR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2T93.GBP","KYMR","NDAQ","BK4139","BK4585","BK4588","IE00BN0W2W23.USD","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","BK4112","IE00BN0W2V16.EUR","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464259","title":"Kymera Therapeutics posts corporate presentation outlining oral immunology protein degrader pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464259","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464259?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:08","pubTimestamp":1781003294,"startTime":"0","endTime":"0","summary":"Kymera outlined a strategy to build an oral targeted protein degradation pipeline in immunology, aiming for biologics-like activity with pill convenience.Lead program KT-621, an oral STAT6 degrader, is positioned as a potential alternative to dupilumab across Type 2 inflammatory diseases.KT-621 Phase 2b atopic dermatitis readout targeted by mid-2027; Phase 2b asthma data targeted in late 2027.Second core program KT-579, an oral IRF5 degrader, targets lupus and other autoimmune diseases; Phase 1 healthy-volunteer data expected in 2H26.Presentation highlighted a large immunology market, citing more than $100 billion in annual sales for advanced therapies and low penetration of systemic options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL6zdjQr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464174","title":"Kymera Therapeutics, Sanofi dose first participant in Phase 1 trial of IRAK4 degrader KT-485","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464174","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464174?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:02","pubTimestamp":1781002961,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics’ partner Sanofi dosed the first participant in a Phase 1 trial of oral IRAK4 degrader KT-485 .No results have been presented; the study is designed to assess safety and drug behavior in healthy volunteers and hidradenitis suppurativa patients.The first dose triggered a USD 20 million milestone payment from Sanofi to Kymera under the collaboration.Sanofi leads development, regulatory, and commercial work; Kymera remains eligible for up to USD 975 million in further milestones.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDLbfh6k2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014039.USD","SG9999014021.USD","SG9999014013.SGD","KYMR","NDAQ","IE00BN0W2W23.USD","BK4112","BK4585","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464655","title":"Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral Irak4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464655?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:00","pubTimestamp":1781002802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUACFGYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464637","title":"Kymera Therapeutics - Eligible for up to $975 Mln in KT-485 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464637?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:00","pubTimestamp":1781002802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUACFGYH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464619","title":"Kymera Therapeutics - Receive S $20 Mln Milestone Payment From Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464619","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464619?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:00","pubTimestamp":1781002802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUACFGYH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642655624","title":"Kymera Therapeutics: Buy Rating Reiterated as Analyst Maintains $110 Price Target on Emerging Protein Degrader Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2642655624","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642655624?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:55","pubTimestamp":1780995318,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Kymera Therapeutics, with a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kymera-therapeutics-buy-rating-reiterated-as-analyst-maintains-110-price-target-on-emerging-protein-degrader-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kymera-therapeutics-buy-rating-reiterated-as-analyst-maintains-110-price-target-on-emerging-protein-degrader-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642432221","title":"Kymera Therapeutics COO Chadwick to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2642432221","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642432221?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:17","pubTimestamp":1780957020,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Chief Operating Officer Jeremy Chadwick is retiring.Chadwick will remain with the company as an adviser through the end of the year, Kymera said Monday. The biotechnology company did not give an exact date for his retirement.Kymera also appointed Penny Carlson to serve as senior vice president, developmental operations. Carlson previously served as head of global clinical development operations at Takeda.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1992135472.HKD","LU2211815571.USD","BK4139","KYMR","BK4585","GB00BDT5M118.USD","BK4588","LU2272731600.USD","COO","BK4198","LU2272731782.SGD","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642073434","title":"Kymera Therapeutics COO Resigns, Transition Plan Implemented","url":"https://stock-news.laohu8.com/highlight/detail?id=2642073434","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642073434?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:10","pubTimestamp":1780953019,"startTime":"0","endTime":"0","summary":"An update from Kymera Therapeutics ( ($KYMR) ) is now available. Kymera Therapeutics announced that Chief Operating Officer Jeremy Chadwick submitt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kymera-therapeutics-coo-resigns-transition-plan-implemented?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kymera-therapeutics-coo-resigns-transition-plan-implemented?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211815571.USD","LU2272731782.SGD","LU1992135472.HKD","LU2272731600.USD","GB00BDT5M118.USD","BK4139","COO","LU1992135399.USD","BK4588","BK4585","BK4198","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431386","title":"Kymera Therapeutics names Penny Carlson SVP, Development Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431386","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431386?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:01","pubTimestamp":1780948885,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics appointed Penny Carlson as senior vice president, development operations to lead global clinical development operations for its oral immunology portfolio.Carlson previously served as vice president and head of global clinical development operations at Takeda, overseeing planning and execution of clinical trials.She earlier held leadership roles at Millennium Pharmaceuticals, Aileron Therapeutics, and other drugmakers.Chief Operating Officer Jeremy Chadwick will retire, remaining an adviser through year-end.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL9RPdD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BKPKM429.USD","BK4585","BK4112","LU2210149790.SGD","RNTX","BK4139","SG9999014021.USD","IE00BN0W2W23.USD","LU0314104364.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","SG9999014039.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","IE00BN0W2V16.EUR","NDAQ","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431846","title":"Kymera Therapeutics Appoints Penny Carlson as Senior Vice President, Development Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431846","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431846?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:01","pubTimestamp":1780948860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA59FTDV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":155,"code":"91000000","status":"200"}]}}